LivaNova (NASDAQ:LIVN) Upgraded at Robert W. Baird

Robert W. Baird upgraded shares of LivaNova (NASDAQ:LIVN) from a neutral rating to an outperform rating in a research report released on Tuesday, Marketbeat.com reports. The firm currently has $66.00 target price on the stock, up from their prior target price of $55.00.

Several other equities research analysts have also issued reports on the company. Needham & Company LLC upped their price target on LivaNova from $72.00 to $75.00 and gave the company a buy rating in a research report on Wednesday, July 31st. Stifel Nicolaus increased their target price on shares of LivaNova from $70.00 to $72.00 and gave the stock a buy rating in a report on Thursday, July 25th. One analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of Buy and an average target price of $70.80.

LivaNova Price Performance

LIVN opened at $51.23 on Tuesday. The company has a market capitalization of $2.77 billion, a P/E ratio of -85.38 and a beta of 1.00. The company has a 50-day moving average of $48.86 and a 200-day moving average of $53.41. The company has a debt-to-equity ratio of 0.49, a quick ratio of 2.94 and a current ratio of 3.45. LivaNova has a 1-year low of $42.75 and a 1-year high of $64.47.

LivaNova (NASDAQ:LIVN) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.66 by $0.15. LivaNova had a positive return on equity of 13.77% and a negative net margin of 1.37%. The firm had revenue of $318.60 million during the quarter, compared to analyst estimates of $305.05 million. Equities analysts expect that LivaNova will post 2.58 EPS for the current fiscal year.

Institutional Investors Weigh In On LivaNova

A number of hedge funds have recently added to or reduced their stakes in LIVN. New York State Teachers Retirement System grew its position in shares of LivaNova by 0.3% during the first quarter. New York State Teachers Retirement System now owns 64,322 shares of the company’s stock worth $3,598,000 after acquiring an additional 200 shares during the last quarter. Arizona State Retirement System grew its position in LivaNova by 2.0% in the 2nd quarter. Arizona State Retirement System now owns 15,104 shares of the company’s stock worth $828,000 after purchasing an additional 299 shares during the last quarter. State of Michigan Retirement System increased its stake in shares of LivaNova by 2.3% in the first quarter. State of Michigan Retirement System now owns 13,211 shares of the company’s stock valued at $739,000 after purchasing an additional 300 shares during the period. Fifth Third Bancorp raised its holdings in shares of LivaNova by 97.1% during the second quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock valued at $37,000 after buying an additional 332 shares during the last quarter. Finally, Hexagon Capital Partners LLC boosted its position in shares of LivaNova by 117.8% during the second quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock worth $37,000 after buying an additional 370 shares during the period. 97.64% of the stock is currently owned by institutional investors.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.